| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.014 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |